Pharmaceutical Technology® Group spoke with Erik Wiklund, CEO of Circio, about the future of M&A in the bio/pharmaceutical industry and the struggle small biotech companies face raising funds.

Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, ...

The Bio Pharmaceuticals Market is a rapidly evolving sector within the healthcare industry, characterized by the development of drugs derived from biological sources. This market has gained ...

Where thousands of former Health and Human Services employees will work next is unknown, but biopharma companies likely ...

The firings of most of the negotiators and their project managers throw into disarray the complex process of reauthorizing ...

Pharmaceutical companies rely on a vast and intricate global ... Trade association Biotechnology Innovation Organization (BIO) released survey results and analysis last month, which highlighted ...

FDA Commissioner Marty Makary last week announced a directive that would limit industry participation in the agency’s ...

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

These companies focused as much on cod liver ... Exhibition is one of the largest and most respected events for bio & pharmaceutical manufacturing professionals.

As the industry advances ... Conference & Exhibition is one of the largest and most respected events for bio & pharmaceutical manufacturing professionals. Waleed Zafar is the mission critical ...

Tariffs on China-made pharmaceuticals would increase production costs for 70% of companies that responded to BIO’s February survey. After China unveiled 34% reciprocal tariffs on all imports ...

To help push that process along, Stoll believes the pharmaceutical industry and its lobbying arms, such as PhRMA and BIO, should collectively work out a new tariff proposal for the Trump ...